Clear Thinking in Data, Cloud, and AI

A new chapter in AI infrastructure may be unfolding far from land. Peter Thiel has led a $140M Series B investment in Panthalassa, an Oregon-based startup building autonomous, wave-powered floating compute platforms. The round reportedly values the company at close to $1B—signaling serious confidence in an unconventional idea: putting AI data centers in the ocean.

⚙️ How It Works

Panthalassa’s approach is equal parts engineering and environmental adaptation:

• Each platform is an 85-meter steel node deployed in open ocean
• Instead of traditional power sources, it converts wave motion into electricity
• AI compute hardware onboard is naturally cooled by seawater, eliminating the need for energy-intensive cooling systems
• The structures are self-steering, using hull design rather than engines to reposition in optimal waters
• Connectivity is handled via SpaceX’s Starlink, transmitting AI outputs back to land-based systems

This is not just about floating infrastructure—it’s about decoupling compute from land constraints entirely.

🏗️ What Comes Next

The new funding will:

• Complete a pilot manufacturing facility near Portland
• Support deployment of the first wave-powered compute nodes in the Pacific
• Target a commercial rollout by 2027

Thiel’s framing is bold—suggesting that compute infrastructure is entering a phase where “extraterrestrial solutions” are becoming viable. While space-based compute remains distant, the ocean offers a near-term, scalable frontier.

🌍 Why This Matters

AI infrastructure is hitting real-world limits:

• Power consumption is skyrocketing
• Cooling requirements are becoming unsustainable
• Public resistance to large data centers is growing

Major players like Elon Musk and Google have explored futuristic alternatives—including space—but those remain long-term bets.

Panthalassa’s model sits in a practical middle ground:

• Ocean = abundant energy + natural cooling
• Offshore deployment = reduced regulatory friction
• Mobility = dynamic optimization of compute locations

🧠 The Bigger Shift

This isn’t just a new type of data center—it’s a signal that AI infrastructure is becoming geographically fluid.

Instead of asking “Where can we build data centers?”, the question is shifting to:

“Where should compute live to maximize efficiency, cost, and sustainability?”

The answer might not be land at all.

https://www.businesswire.com/news/home/20260504552400/en/Panthalassa-Raises-%24140-Million-to-Power-AI-at-Sea?utm_source=www.therundown.ai

A new study out of Harvard University, published in Science, is raising serious questions about the future role of AI in clinical decision-making.

Researchers evaluated OpenAI o1-preview using 76 real emergency room (ER) cases—and the results weren’t subtle. The AI didn’t just perform well. It outperformed experienced physicians.

What the Study Tested

The study wasn’t theoretical or synthetic. It used:

• Real ER patient cases
• Raw electronic health record (EHR) text
• Three stages of clinical decision-making

The AI had no special formatting, no structured prompts—just the same messy, real-world data clinicians deal with every day.

The Results: AI Took the Lead

At the initial ER triage stage, accuracy rates were:

• 67.1% — AI (o1-preview)
• 55.3% — Physician #1
• 50.0% — Physician #2

That’s not a marginal improvement—it’s a double-digit lead in diagnostic accuracy at the most critical early stage of care.

Even more interesting:

• Independent physician reviewers could not distinguish between AI-generated and human diagnoses.

In other words, the AI didn’t just perform better—it blended in seamlessly with expert-level clinical reasoning.

A Real-World Moment That Stands Out

One case in particular highlights the potential impact:

• The AI flagged a rare flesh-eating infection (necrotizing condition)
• In a transplant patient
• 12–24 hours before the treating physician identified it

That kind of time advantage isn’t academic—it can be the difference between life and death.

What This Actually Means (And What It Doesn’t)

Let’s be clear: this does not mean AI is replacing doctors.

But it does signal something more practical—and arguably more powerful:

1. AI as a Second Set of Eyes

Doctors operate under pressure, fatigue, and time constraints. AI doesn’t.
A system that consistently flags edge cases or rare conditions can act as a real-time diagnostic safety net.

2. Pattern Recognition at Scale

AI models trained across vast datasets can detect patterns that are:

• Rare
• Non-obvious
• Easily missed in fast-paced environments like ERs

3. Decision Augmentation, Not Automation

The real value isn’t in replacing clinicians—it’s in augmenting their judgment, especially during:

• Triage
• Differential diagnosis
• Risk identification

The Bigger Shift: AI Helping Doctors, Not Just Patients

Millions of people already use AI tools for personal health questions.

This study flips the narrative:

AI isn’t just for patients anymore—it’s becoming a tool for clinicians themselves.

And if a 2024-era model is already outperforming physicians in controlled settings, the trajectory is hard to ignore.

Where This Could Go Next

If integrated responsibly into clinical workflows, AI could:

• Reduce diagnostic errors
• Improve triage prioritization
• Accelerate identification of rare conditions
• Provide continuous clinical support in high-load environments

But this also raises real questions:

• How do we validate and regulate these systems?
• Who is accountable for AI-assisted decisions?
• How do we integrate without over-reliance?

Final Thought

We’re not looking at a distant future scenario anymore.

We’re looking at a present-day signal:

AI is already capable of matching—and in some cases exceeding—human diagnostic performance in high-stakes environments.

The next phase isn’t about proving capability.

It’s about figuring out how to safely and effectively put that capability to work inside real healthcare systems.

https://www.science.org/doi/10.1126/science.adz4433

A growing dispute between the White House and Anthropic is exposing a deeper issue in the AI race: who gets access to the most powerful models — and when.

At the center of the debate is Anthropic’s advanced AI system, Mythos, and a proposed expansion that would significantly increase private-sector access.

🔍 What’s Happening

Anthropic had plans to expand Mythos access from roughly 50 companies to nearly 120. On paper, it looks like a typical scale-up move. In practice, it triggered concern inside the U.S. government.

Officials pushed back, citing compute constraints — the fear that expanding access could strain infrastructure and limit availability for federal use, particularly in sensitive domains tied to defense and intelligence.

This friction comes as a new AI policy memo from the White House is being finalized — one that could reshape how agencies adopt and procure AI systems.

🧠 Policy Shift: Multi-Vendor AI Strategy

The upcoming memo is expected to encourage multi-vendor AI adoption across federal agencies, reducing reliance on any single provider.

This is a notable shift.

It also reportedly includes provisions that would allow agencies to bypass certain supply chain risk classifications, a move that could ease tensions with companies like Anthropic — even as legal and strategic disagreements continue.

In short: the government wants flexibility, redundancy, and leverage.

⚔️ Internal Friction in Washington

The situation isn’t just a government vs. company issue — there’s also disagreement within Washington.

Comments from figures like Pete Hegseth highlight a harder stance toward Anthropic, while others appear more focused on ensuring continued access to frontier AI capabilities.

This reflects a broader split:

• One side prioritizes control, risk mitigation, and ideological scrutiny
• The other prioritizes access, capability, and strategic advantage

🤖 The Bigger Picture: AI Parity Is Coming Fast

Adding urgency to the situation, models like GPT-5.5 are reportedly approaching similar cyber and reasoning capabilities as Mythos.

Former AI policy lead David Sacks suggested that most frontier models could reach comparable capability levels within six months.

If that timeline holds, exclusivity becomes temporary — and the battle shifts from who has access to how widely it’s deployed.

⚠️ Why It Matters

This isn’t just a policy disagreement — it’s a preview of how AI power will be managed:

• Compute is now a strategic resource, not just a technical constraint
• Access to frontier models is becoming a geopolitical lever
• Government and private sector priorities are increasingly misaligned

The White House appears to be recalibrating — not necessarily backing away from Anthropic, but ensuring it doesn’t become dependent on any single player.

At the same time, internal divisions suggest that the U.S. is still figuring out how to balance innovation, control, and national security in the AI era.

If you zoom out, the signal is clear:
AI isn’t just a technology race anymore — it’s an infrastructure, policy, and power struggle all at once.

https://www.wsj.com/tech/ai/white-house-opposes-anthropics-plan-to-expand-access-to-mythos-model-dc281ab5

The push to scale AI beyond text and images is heading straight into biology—and the stakes couldn’t be higher.

Backed by Mark Zuckerberg and Priscilla Chan, the Chan Zuckerberg Initiative’s Biohub has announced a $500M Virtual Biology Initiative aimed at building massive, open datasets and models that can predict how human cells behave.

The Big Bet: Data First, Models Second

The initiative is structured around a simple but ambitious premise: biology needs better data before AI can truly transform it.

• $400M is earmarked for large-scale data generation and advanced imaging technologies
• $100M will support external labs and collaborative research
• Partners include organizations like Nvidia and the Allen Institute

Biohub is also committing to open datasets, positioning this as shared infrastructure rather than a closed, proprietary race.

Why This Matters: Biology Isn’t Language

Today’s AI breakthroughs were fueled by internet-scale data. Biology isn’t there yet.

Current datasets top out around ~1 billion cells, but researchers like Alex Rives argue we need an order of magnitude more to unlock meaningful predictive power. The goal isn’t just classification—it’s simulation:

• Predict how cells respond to drugs
• Understand disease progression at a molecular level
• Eventually reprogram biological systems

That’s a leap from analyzing biology → to modeling and controlling it.

The Long-Term Vision

The ambition aligns with ideas from leaders like Demis Hassabis, who has suggested AI could one day help eliminate disease entirely.

Biohub’s approach is essentially:

Build the dataset → train the models → simulate biology → intervene with precision

The Real Question

We’ve seen scaling laws transform language models and protein folding. But biology is messier, noisier, and far less standardized.

Will scaling data unlock cellular intelligence the same way it unlocked GPT-level reasoning?
Or does biology require fundamentally new paradigms beyond brute-force scale?

Bottom Line

Biohub isn’t just funding research—it’s attempting to build the foundational data layer for AI-driven biology.

If it works, this could mark the shift from AI as a tool for discovery…
to AI as a system for designing and controlling life at the cellular level.

https://biohub.org/news/virtual-biology-initiative